Latest Breaking News On - Virpax pharmaceuticals - Page 3 : comparemela.com

Virpax Pharmaceuticals (VRPX) Files for Share and Warrant Offering

Virpax Pharmaceuticals (VRPX) Files for Share and Warrant Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Virpax pharmaceuticalsCommon stockCommon warrantNasdaq capital marketCommon warrantsEach pre funded warrantPre funded warrantsPre funded warrant

Virpax Pharmaceuticals Reports 2023 Year-End Results

Virpax Pharmaceuticals Reports 2023 Year-End Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesGeraldw bruceVirpax probudurAnthonyp mackBoard of directors the companyMolecular envelope technologyUs army institute of surgical researchSecurities exchangeExchange commissionScilex pharmaceuticals incNational institutes of healthDevelopment agreementUs department of defensePharmaceuticals incSorrento therapeutics incVirpax pharmaceuticals

Shares of Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX – Free Report) are going to reverse split before the market opens on Friday, March 1st. The 1-10 reverse split was announced on Friday, March 1st. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, March 1st. Virpax Pharmaceuticals Price Performance Shares […]

Virpax pharmaceuticals company profileVirpax pharmaceuticals price performanceCitigroup incNews ratings for virpax pharmaceuticals dailyVirpax pharmaceuticals incVanguard group incVirpax pharmaceuticalsRenaissance technologiesFree reportVanguard groupGet free reportVirpax pharmaceuticals dailyNasdaq vrpxStock split

Scilex Holding Company s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc , Enters into a Term Sheet with Virpax Pharmaceuticals, Inc Regarding a Mutual Release and Settlement Agreement - Scilex Holding (NASDAQ:SCLX)

PALO ALTO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company")), an innovative revenue-generating company focused on acquiring, developing and commercializing

Palo altoUnited statesAnthony mackScilex pharmaScilex or companyDrug administrationScilex holding companyScilex pharmaceuticals incVirpax pharmaceuticals incExchange commissionSemnur pharmaceuticals incScilex holding company all rightsSorrento therapeutics incScilex pharmaceuticalsSorrento therapeuticsVirpax pharmaceuticals

Latest Breaking News On - Virpax pharmaceuticals - Page 3 : comparemela.com

Virpax Pharmaceuticals (VRPX) Files for Share and Warrant Offering

Virpax Pharmaceuticals Reports 2023 Year-End Results

12 Health Care Stocks Moving In Tuesday s After-Market Session - Akili (NASDAQ:AKLI), Apollomics (NASDAQ:APLM)

Coeptis therapeuticsBiosig technologiesCara therapeuticsAmira pharmaceuticalsVirpax pharmaceuticalsEstrella immunopharma

Virpax Pharmaceuticals Stock to Reverse Split on Friday, March 1st (NASDAQ:VRPX)

Scilex Holding Company s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc , Enters into a Term Sheet with Virpax Pharmaceuticals, Inc Regarding a Mutual Release and Settlement Agreement - Scilex Holding (NASDAQ:SCLX)